CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | propanal |
|
Accession: | CHEBI:17153
|
browse the term
|
Definition: | An aldehyde that consists of ethane bearing a formyl substituent. The parent of the class of propanals. |
Synonyms: | related_synonym: | 1-Propanal; Aldehyde propionique; C2H5CHO; Formula=C3H6O; InChI=1S/C3H6O/c1-2-3-4/h3H,2H2,1H3; InChIKey=NBBJYMSMWIIQGU-UHFFFAOYSA-N; Methylacetaldehyde; Propaldehyde; Propanaldehyde; Propional; Propionaldehyde; Propionic aldehyde; Propyl aldehyde; Propylaldehyde; Propylic aldehyde; SMILES=[H]C(=O)CC; n-Propanal; n-Propionaldehyde |
| alt_id: | CHEBI:14898; CHEBI:26281; CHEBI:41359; CHEBI:45052; CHEBI:8468 |
| xref: | CAS:123-38-6; HMDB:HMDB0003366; KEGG:C00479 |
| xref_mesh: | MESH:C005556 |
| xref: | MetaCyc:CPD-665; PDBeChem:CBG; PMID:20097366; PMID:21568340; Reaxys:506010; UM-BBD_compID:c0207; Wikipedia:Propanal |
|
|
|
G |
1700012B09Rik |
RIKEN cDNA 1700012B09 gene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C11ORF97 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:14,667,888...14,682,345
Ensembl chr 9:14,667,883...14,682,326
|
|
G |
2310057J18Rik |
RIKEN cDNA 2310057J18 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C6ORF58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:28,848,284...28,862,302
Ensembl chr10:28,848,284...28,862,299
|
|
G |
2900092C05Rik |
RIKEN cDNA 2900092C05 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C19ORF18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:12,246,391...12,290,250
Ensembl chr 7:12,246,444...12,290,250
|
|
G |
4921504E06Rik |
RIKEN cDNA 4921504E06 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C10ORF67 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:19,467,648...19,558,721
Ensembl chr 2:19,467,648...19,558,725
|
|
G |
4930444P10Rik |
RIKEN cDNA 4930444P10 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C8ORF89 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:16,136,198...16,163,549
Ensembl chr 1:16,136,203...16,163,549
|
|
G |
4930562C15Rik |
RIKEN cDNA 4930562C15 gene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C16ORF96 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:4,653,280...4,685,555
Ensembl chr16:4,653,280...4,685,550
|
|
G |
4933405L10Rik |
RIKEN cDNA 4933405L10 gene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C16ORF86 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:106,434,921...106,436,877
Ensembl chr 8:106,434,287...106,436,878
|
|
G |
4933430I17Rik |
RIKEN cDNA 4933430I17 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C9ORF43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:62,443,541...62,471,270
Ensembl chr 4:62,443,606...62,466,230
|
|
G |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of LINC00261 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:147,786,383...147,882,123
Ensembl chr 2:147,785,944...147,882,569
|
|
G |
9130008F23Rik |
RIKEN cDNA 9130008F23 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C6ORF141 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:41,186,373...41,191,449
Ensembl chr17:41,186,373...41,191,450
|
|
G |
9530057J20Rik |
RIKEN cDNA 9530057J20 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of POTEM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:20,478,979...20,510,931
Ensembl chr 8:20,478,993...20,501,314
|
|
G |
A1bg |
alpha-1-B glycoprotein |
increases expression |
ISO |
propionaldehyde results in increased expression of A1BG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:60,789,438...60,793,119
Ensembl chr15:60,768,708...60,794,861
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
ISO |
propionaldehyde results in increased expression of A2M mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
|
|
G |
A930018P22Rik |
RIKEN cDNA A930018P22 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of C11ORF91 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:103,953,114...103,955,091
Ensembl chr 2:103,953,114...103,955,094
|
|
G |
AA467197 |
expressed sequence AA467197 |
increases expression |
ISO |
propionaldehyde results in increased expression of C15ORF48 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:122,479,807...122,482,996
Ensembl chr 2:122,478,906...122,483,111
|
|
G |
AA986860 |
expressed sequence AA986860 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF116 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:130,659,707...130,672,359
Ensembl chr 1:130,659,713...130,672,359
|
|
G |
Aanat |
arylalkylamine N-acetyltransferase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AANAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:116,482,547...116,489,022
Ensembl chr11:116,477,258...116,488,506
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
ISO |
propionaldehyde results in increased expression of AASS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of ABAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A member 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Abca4 |
ATP-binding cassette, sub-family A member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:121,837,547...121,973,719
Ensembl chr 3:121,838,092...121,973,772
|
|
G |
Abcb5 |
ATP-binding cassette, sub-family B member 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCB5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:118,831,221...118,930,169
Ensembl chr12:118,831,559...118,930,156
|
|
G |
Abcc3 |
ATP-binding cassette, sub-family C member 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
|
|
G |
Abcc6 |
ATP-binding cassette, sub-family C member 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCC6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCG4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:44,184,485...44,199,953
Ensembl chr 9:44,184,485...44,199,912
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCG5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
|
|
G |
Abhd8 |
abhydrolase domain containing 8 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABHD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:71,909,344...71,917,351
Ensembl chr 8:71,909,349...71,916,299
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABLIM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:61,932,463...62,044,956
Ensembl chr18:61,932,463...62,044,895
|
|
G |
Acmsd |
amino carboxymuconate semialdehyde decarboxylase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ACMSD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:127,657,149...127,695,723
Ensembl chr 1:127,657,150...127,695,715
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ACOT4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:84,084,028...84,091,497
Ensembl chr12:84,085,153...84,095,375
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of ACOT9 gene |
CTD |
PMID:30002397 |
|
NCBI chr X:154,045,439...154,080,650
Ensembl chr X:154,045,439...154,080,650
|
|
G |
Acrv1 |
acrosomal vesicle protein 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ACRV1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:36,604,550...36,610,139
Ensembl chr 9:36,604,516...36,610,139
|
|
G |
Acta1 |
actin alpha 1, skeletal muscle |
increases expression |
ISO |
propionaldehyde results in increased expression of ACTA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
increases expression |
ISO |
propionaldehyde results in increased expression of ACTA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Acvrl1 |
activin A receptor, type II-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ACVRL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:101,026,403...101,043,217
Ensembl chr15:101,026,403...101,043,217
|
|
G |
Adam11 |
a disintegrin and metallopeptidase domain 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:102,652,261...102,671,089
Ensembl chr11:102,652,265...102,671,088
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:45,945,329...46,038,174
Ensembl chr11:45,946,819...46,038,170
|
|
G |
Adam21 |
a disintegrin and metallopeptidase domain 21 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:81,605,349...81,615,248
Ensembl chr12:81,605,358...81,615,248
|
|
G |
Adam33 |
a disintegrin and metallopeptidase domain 33 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAM33 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:130,892,739...130,905,734
Ensembl chr 2:130,892,511...130,905,734
|
|
G |
Adamts10 |
ADAM metallopeptidase with thrombospondin type 1 motif 10 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:33,742,620...33,772,756
Ensembl chr17:33,743,178...33,772,756
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:61,032,886...61,109,447
Ensembl chr10:61,032,891...61,109,217
|
|
G |
Adamts17 |
ADAM metallopeptidase with thrombospondin type 1 motif 17 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:66,487,387...66,802,373
Ensembl chr 7:66,489,483...66,802,919
|
|
G |
Adamts19 |
ADAM metallopeptidase with thrombospondin type 1 motif 19 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:58,967,819...59,186,754
Ensembl chr18:58,969,739...59,187,132
|
|
G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:171,077,698...171,089,836
Ensembl chr 1:171,077,990...171,088,206
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:104,423,026...104,633,203
Ensembl chr13:104,424,343...104,633,203
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTSL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:81,984,612...82,263,658
Ensembl chr 7:81,984,902...82,263,658
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:95,583,511...95,595,232
Ensembl chr 3:95,583,511...95,595,228
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:80,044,869...80,071,449
Ensembl chr11:80,044,931...80,069,784
|
|
G |
Adgra2 |
adhesion G protein-coupled receptor A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:27,575,546...27,613,464
Ensembl chr 8:27,575,611...27,613,464
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:74,388,045...74,461,314
Ensembl chr15:74,388,044...74,461,314
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:57,665,650...57,790,527
Ensembl chr17:57,665,691...57,790,527
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:42,967,099...43,008,460
Ensembl chr17:42,967,782...43,003,175
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRV1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:81,243,187...81,781,504
Ensembl chr13:81,243,187...81,781,273
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADH1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
|
|
G |
Adh6b |
alcohol dehydrogenase 6B (class V) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADH6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:138,047,176...138,064,621
Ensembl chr 3:138,047,536...138,064,622
|
|
G |
Adora2a |
adenosine A2a receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of ADORA2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
|
|
G |
Adrb1 |
adrenergic receptor, beta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADRB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Adtrp |
androgen dependent TFPI regulating protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ADTRP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:41,916,621...42,001,092
Ensembl chr13:41,916,624...42,001,160
|
|
G |
Afap1l2 |
actin filament associated protein 1-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AFAP1L2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:56,900,786...57,017,021
Ensembl chr19:56,900,793...56,996,660
|
|
G |
Aff2 |
AF4/FMR2 family, member 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AFF2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:68,403,796...68,915,660
Ensembl chr X:68,403,900...68,911,643
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AGAP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:126,911,154...126,929,039
Ensembl chr10:126,911,153...126,929,038
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
Agt |
angiotensinogen |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGTR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AHNAK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:112,738,631...112,766,278
Ensembl chr12:112,738,628...112,766,277
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
ISO |
propionaldehyde results in increased expression of AHRR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:74,359,237...74,440,450
Ensembl chr13:74,359,237...74,440,450
|
|
G |
AI593442 |
expressed sequence AI593442 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C11ORF87 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:52,584,332...52,593,434
Ensembl chr 9:52,584,342...52,591,080
|
|
G |
Aif1l |
allograft inflammatory factor 1-like |
increases expression |
ISO |
propionaldehyde results in increased expression of AIF1L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:31,840,315...31,863,454
Ensembl chr 2:31,840,151...31,863,454
|
|
G |
Aire |
autoimmune regulator |
increases methylation |
ISO |
propionaldehyde results in increased methylation of AIRE gene |
CTD |
PMID:30002397 |
|
NCBI chr10:77,865,856...77,879,444
Ensembl chr10:77,865,856...77,879,444
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
affects reduction increases reduction |
ISO |
AKR1B1 protein affects the reduction of propionaldehyde analog AKR1B1 protein results in increased reduction of propionaldehyde |
CTD |
PMID:9890881 PMID:11306073 |
|
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
|
|
G |
Akr1c6 |
aldo-keto reductase family 1, member C6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AKR1C4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
increases oxidation multiple interactions increases metabolic processing |
ISO EXP |
ALDH1A1 protein results in increased oxidation of propionaldehyde [ALDH1A1 protein binds to NAD] which results in increased oxidation of propionaldehyde; [ALDH1A1 protein co-treated with NAD] results in increased oxidation of propionaldehyde; [NAD co-treated with propionaldehyde] inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein]; propionaldehyde inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein] ALDH1A1 protein results in increased metabolism of propionaldehyde |
CTD |
PMID:10559215 PMID:10856427 PMID:10998257 PMID:21256123 PMID:21349255 PMID:22339434 PMID:25450233 More...
|
|
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase family 1, subfamily A3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
multiple interactions |
ISO |
[ALDH1B1 protein co-treated with NAD] results in increased metabolism of propionaldehyde |
CTD |
PMID:7779080 |
|
NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ALDH1L1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:90,527,751...90,576,153
Ensembl chr 6:90,463,409...90,577,185
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
affects metabolic processing increases oxidation increases metabolic processing multiple interactions |
ISO |
ALDH2 protein polymorphism affects the metabolism of propionaldehyde ALDH2 protein results in increased oxidation of propionaldehyde ALDH2 protein results in increased metabolism of propionaldehyde daidzin inhibits the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; Magnesium promotes the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; molinate inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate metabolite inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate sulfoxide inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde] |
CTD |
PMID:11744614 PMID:20954713 PMID:21349255 PMID:23295226 |
|
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase family 3, subfamily A1 |
increases metabolic processing |
EXP ISO |
ALDH3A1 protein results in increased metabolism of propionaldehyde |
CTD |
PMID:19822198 PMID:21256123 |
|
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ALDH3B1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:3,963,491...3,980,898
Ensembl chr19:3,963,491...3,979,808
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ALDH4A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:139,348,404...139,377,002
Ensembl chr 4:139,350,177...139,377,001
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
increases expression |
ISO |
propionaldehyde results in increased expression of ALOX5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ALOX5AP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
|
|
G |
Ambp |
alpha 1 microglobulin/bikunin precursor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AMBP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
|
|
G |
Amhr2 |
anti-Mullerian hormone type 2 receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of AMHR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:102,353,437...102,363,075
Ensembl chr15:102,353,802...102,363,068
|
|
G |
Amotl1 |
angiomotin-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMOTL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:14,453,262...14,574,408
Ensembl chr 9:14,453,262...14,556,352
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMPD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612
|
|
G |
Amph |
amphiphysin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AMPH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:19,132,524...19,335,089
Ensembl chr13:19,132,375...19,335,091
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANGPT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
|
|
G |
Ank |
progressive ankylosis |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANKH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:27,466,763...27,594,995
Ensembl chr15:27,466,763...27,594,995
|
|
G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKDD1A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:65,395,746...65,427,691
Ensembl chr 9:65,395,752...65,427,475
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:42,024,358...42,033,550
Ensembl chr19:42,024,439...42,033,549
|
|
G |
Ankrd29 |
ankyrin repeat domain 29 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD29 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:12,385,414...12,439,067
Ensembl chr18:12,385,419...12,438,854
|
|
G |
Ankrd34a |
ankyrin repeat domain 34A |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD34A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:96,503,599...96,507,442
Ensembl chr 3:96,503,952...96,507,091
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD34B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:92,562,413...92,578,166
Ensembl chr13:92,562,404...92,578,166
|
|
G |
Ankrd55 |
ankyrin repeat domain 55 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD55 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:112,424,985...112,523,391
Ensembl chr13:112,424,985...112,520,536
|
|
G |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANKS4B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:119,773,081...119,782,939
Ensembl chr 7:119,773,081...119,784,809
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANLN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:22,243,305...22,302,132
Ensembl chr 9:22,243,308...22,300,484
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANP32B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:46,450,926...46,472,657
Ensembl chr 4:46,450,902...46,472,657
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANP32E mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:95,836,557...95,854,699
Ensembl chr 3:95,836,558...95,854,702
|
|
G |
Antxr1 |
anthrax toxin receptor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANTXR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803
|
|
G |
Antxr2 |
anthrax toxin receptor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANTXR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:98,032,547...98,178,876
Ensembl chr 5:98,030,642...98,178,902
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANXA10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:62,510,076...62,576,227
Ensembl chr 8:62,510,076...62,576,184
|
|
G |
Anxa11 |
annexin A11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANXA11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:25,842,575...25,887,228
Ensembl chr14:25,842,580...25,887,228
|
|
G |
Anxa13 |
annexin A13 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANXA13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:58,204,860...58,261,123
Ensembl chr15:58,204,867...58,261,093
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANXA6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AOC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:101,221,432...101,230,256
Ensembl chr11:101,221,431...101,232,764
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AOX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:58,068,963...58,145,569
Ensembl chr 1:58,069,090...58,145,572
|
|
G |
Ap1m2 |
adaptor protein complex AP-1, mu 2 subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AP1M2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:21,206,753...21,223,617
Ensembl chr 9:21,205,571...21,223,633
|
|
G |
Ap1s1 |
adaptor protein complex AP-1, sigma 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AP1S1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:137,063,852...137,074,917
Ensembl chr 5:137,063,847...137,074,989
|
|
G |
Ap1s3 |
adaptor-related protein complex AP-1, sigma 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AP1S3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:79,584,593...79,649,736
Ensembl chr 1:79,584,593...79,649,689
|
|
G |
Apoa1 |
apolipoprotein A-I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
|
|
G |
Apobec3 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of APOBEC3H mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:79,774,620...79,802,419
Ensembl chr15:79,775,860...79,800,107
|
|
G |
Apod |
apolipoprotein D |
increases expression |
ISO |
propionaldehyde results in increased expression of APOD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
ISO |
propionaldehyde results in increased expression of APOE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
|
|
G |
Apoh |
apolipoprotein H |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222
|
|
G |
Apol6 |
apolipoprotein L 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOL6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:76,929,195...76,941,308
Ensembl chr15:76,928,929...76,941,306
|
|
G |
Apol9a |
apolipoprotein L 9a |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:77,287,989...77,295,280
Ensembl chr15:77,287,989...77,295,335
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of APOLD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:134,958,964...134,963,799
Ensembl chr 6:134,958,681...134,963,799
|
|
G |
Aqp3 |
aquaporin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AQP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
|
|
G |
Arc |
activity regulated cytoskeletal-associated protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ARC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
propionaldehyde results in increased expression of AREG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
|
|
G |
Arg2 |
arginase type II |
increases expression |
ISO |
propionaldehyde results in increased expression of ARG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARHGAP11A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:113,661,837...113,679,006
Ensembl chr 2:113,661,837...113,679,006
|
|
G |
Arhgap22 |
Rho GTPase activating protein 22 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGAP22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:32,935,952...33,091,893
Ensembl chr14:32,935,983...33,091,891
|
|
G |
Arhgap25 |
Rho GTPase activating protein 25 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGAP25 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:87,435,526...87,510,241
Ensembl chr 6:87,435,527...87,510,241
|
|
G |
Arhgdib |
Rho, GDP dissociation inhibitor beta |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGDIB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGEF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:34,717,263...34,851,819
Ensembl chr 1:34,717,269...34,852,390
|
|
G |
Arl14 |
ADP-ribosylation factor-like 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARL14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:69,129,752...69,130,951
Ensembl chr 3:69,129,752...69,130,951
|
|
G |
Arl4c |
ADP-ribosylation factor-like 4C |
increases expression |
ISO |
propionaldehyde results in increased expression of ARL4C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:88,625,947...88,629,913
Ensembl chr 1:88,600,847...88,629,943
|
|
G |
Armc3 |
armadillo repeat containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:19,203,676...19,315,054
Ensembl chr 2:19,204,113...19,315,052
|
|
G |
Armh1 |
armadillo-like helical domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMH1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:117,070,523...117,109,329
Ensembl chr 4:117,070,531...117,109,322
|
|
G |
Armh4 |
armadillo-like helical domain containing 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:49,919,017...50,020,843
Ensembl chr14:49,913,409...50,020,840
|
|
G |
Arrb1 |
arrestin, beta 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:99,184,356...99,255,979
Ensembl chr 7:99,184,673...99,255,978
|
|
G |
Arsg |
arylsulfatase G |
increases expression |
ISO |
propionaldehyde results in increased expression of ARSG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:109,364,159...109,464,156
Ensembl chr11:109,364,200...109,464,156
|
|
G |
Arsi |
arylsulfatase i |
increases expression |
ISO |
propionaldehyde results in increased expression of ARSI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:61,045,063...61,051,633
Ensembl chr18:61,044,852...61,051,633
|
|
G |
Art2b |
ADP-ribosyltransferase 2b |
increases expression |
ISO |
propionaldehyde results in increased expression of TIGD7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:101,224,936...101,234,790
Ensembl chr 7:101,226,177...101,234,807
|
|
G |
Art4 |
ADP-ribosyltransferase 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ART4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:136,825,449...136,834,598
Ensembl chr 6:136,825,449...136,834,731
|
|
G |
Arvcf |
armadillo repeat gene deleted in velocardiofacial syndrome |
increases expression |
ISO |
propionaldehyde results in increased expression of ARVCF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:18,166,046...18,225,826
Ensembl chr16:18,166,046...18,225,826
|
|
G |
Arx |
aristaless related homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:92,330,113...92,341,963
Ensembl chr X:92,330,051...92,341,963
|
|
G |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASB18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,880,313...89,942,388
Ensembl chr 1:89,877,942...89,942,388
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:103,287,401...103,322,260
Ensembl chr12:103,287,401...103,322,260
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:5,383,386...5,433,022
Ensembl chr 6:5,383,386...5,433,022
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASF1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASGR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:69,939,735...69,948,721
Ensembl chr11:69,944,911...69,948,720
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASGR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:69,983,470...69,997,013
Ensembl chr11:69,983,470...69,997,013
|
|
G |
Asmt |
acetylserotonin O-methyltransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of ASMT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:169,106,379...169,111,787
Ensembl chr X:169,106,280...169,112,125
|
|
G |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASPHD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:112,532,220...112,543,236
Ensembl chr 5:112,532,220...112,542,732
|
|
G |
Aspm |
abnormal spindle microtubule assembly |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASPM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829
|
|
G |
Ass1 |
argininosuccinate synthetase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
|
|
G |
Astn2 |
astrotactin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASTN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:65,299,040...66,322,774
Ensembl chr 4:65,299,040...66,322,848
|
|
G |
Atcay |
ataxia, cerebellar, Cayman type |
increases expression |
ISO |
propionaldehyde results in increased expression of ATCAY mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:81,040,338...81,067,037
Ensembl chr10:81,040,342...81,066,667
|
|
G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP1A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631
|
|
G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP1B2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768
|
|
G |
Atp2a3 |
ATPase, Ca++ transporting, ubiquitous |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP2A3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:72,851,995...72,883,869
Ensembl chr11:72,851,995...72,883,870
|
|
G |
Atp4a |
ATPase, H+/K+ exchanging, gastric, alpha polypeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP4A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:30,411,634...30,424,959
Ensembl chr 7:30,411,634...30,424,959
|
|
G |
Atp6v0a4 |
ATPase, H+ transporting, lysosomal V0 subunit A4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP6V0A4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:38,025,418...38,101,521
Ensembl chr 6:38,025,418...38,101,521
|
|
G |
Atp8b3 |
ATPase, class I, type 8B, member 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP8B3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:80,355,418...80,374,987
Ensembl chr10:80,355,418...80,374,958
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AURKB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
|
|
G |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of B3GALT4 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr17:34,168,886...34,170,462
Ensembl chr17:34,168,883...34,170,462
|
|
G |
B3gnt6 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of B3GNT6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:97,841,622...97,848,682
Ensembl chr 7:97,841,624...97,848,688
|
|
G |
Baat |
bile acid-Coenzyme A: amino acid N-acyltransferase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BAAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
|
|
G |
Baiap3 |
BAI1-associated protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BAIAP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:25,461,633...25,475,255
Ensembl chr17:25,461,633...25,475,338
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BARD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:71,066,694...71,142,300
Ensembl chr 1:71,066,657...71,142,305
|
|
G |
Barx1 |
BarH-like homeobox 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BARX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:48,816,512...48,819,983
Ensembl chr13:48,816,474...48,819,983
|
|
G |
Batf2 |
basic leucine zipper transcription factor, ATF-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BATF2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:6,214,424...6,222,506
Ensembl chr19:6,191,013...6,222,506
|
|
G |
Batf3 |
basic leucine zipper transcription factor, ATF-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BATF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:190,830,611...190,841,140
Ensembl chr 1:190,830,044...190,841,142
|
|
G |
BC028528 |
cDNA sequence BC028528 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF54 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:95,789,665...95,800,186
Ensembl chr 3:95,791,266...95,799,317
|
|
G |
Bcl11a |
BCL11 transcription factor A |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL11A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:24,026,498...24,123,558
Ensembl chr11:24,028,056...24,124,123
|
|
G |
Bcl2a1b |
B cell leukemia/lymphoma 2 related protein A1b |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL2A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:89,081,326...89,089,891
Ensembl chr 9:89,081,262...89,089,880
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL2L10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:75,255,040...75,258,922
Ensembl chr 9:75,255,040...75,258,931
|
|
G |
Bco2 |
beta-carotene oxygenase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:50,444,387...50,466,513
Ensembl chr 9:50,444,387...50,466,481
|
|
G |
Bdnf |
brain derived neurotrophic factor |
increases expression |
ISO |
propionaldehyde results in increased expression of BDNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Bex1 |
brain expressed X-linked 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BEX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:135,114,721...135,116,262
Ensembl chr X:135,114,721...135,116,262
|
|
G |
Bex4 |
brain expressed X-linked 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of BEX4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:135,039,745...135,041,192
Ensembl chr X:135,039,745...135,041,192
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
ISO |
propionaldehyde results in increased expression of BHLHE41 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:145,803,969...145,811,146
Ensembl chr 6:145,803,969...145,811,284
|
|
G |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BICRA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:15,704,596...15,785,047
Ensembl chr 7:15,704,597...15,781,846
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
ISO |
propionaldehyde results in increased expression of BIK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:83,410,992...83,428,836
Ensembl chr15:83,411,063...83,428,835
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BIRC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BIRC5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Blm |
Bloom syndrome, RecQ like helicase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BLM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:80,104,839...80,184,896
Ensembl chr 7:80,104,481...80,184,867
|
|
G |
Bmp10 |
bone morphogenetic protein 10 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of BMP10 gene |
CTD |
PMID:30002397 |
|
NCBI chr 6:87,405,976...87,411,494
Ensembl chr 6:87,405,976...87,414,659
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BMP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of BMP7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114
|
|
G |
Bmp8a |
bone morphogenetic protein 8a |
increases expression |
ISO |
propionaldehyde results in increased expression of BMP8A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:123,206,438...123,237,045
Ensembl chr 4:123,206,438...123,237,045
|
|
G |
Bmper |
BMP-binding endothelial regulator |
increases expression |
ISO |
propionaldehyde results in increased expression of BMPER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:23,134,372...23,396,511
Ensembl chr 9:23,134,372...23,396,496
|
|
G |
Brca1 |
breast cancer 1, early onset |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRCA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
|
|
G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRIP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:85,948,957...86,092,041
Ensembl chr11:85,948,964...86,092,019
|
|
G |
Brpf3 |
bromodomain and PHD finger containing, 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRPF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:29,020,088...29,057,763
Ensembl chr17:29,020,064...29,058,923
|
|
G |
Btbd17 |
BTB domain containing 17 |
increases expression |
ISO |
propionaldehyde results in increased expression of BTBD17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:114,681,495...114,692,738
Ensembl chr11:114,682,043...114,686,771
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BTG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
|
|
G |
Bub1 |
BUB1, mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BUB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785
|
|
G |
Bub1b |
BUB1B, mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BUB1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:118,428,684...118,472,073
Ensembl chr 2:118,428,692...118,472,072
|
|
G |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
|
|
G |
C1ql4 |
complement component 1, q subcomponent-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1QL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:98,981,967...98,988,555
Ensembl chr15:98,981,967...98,985,698
|
|
G |
C1qtnf5 |
C1q and tumor necrosis factor related protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QTNF5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:44,013,067...44,020,484
Ensembl chr 9:44,018,542...44,020,484
|
|
G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QTNF6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:78,407,546...78,416,370
Ensembl chr15:78,407,546...78,415,616
|
|
G |
C1rb |
complement component 1, r subcomponent B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130
|
|
G |
C1s1 |
complement component 1, s subcomponent 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1S mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:124,507,303...124,519,340
Ensembl chr 6:124,507,304...124,519,318
|
|
G |
C2 |
complement C2 |
increases expression |
ISO |
propionaldehyde results in increased expression of C2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:35,081,578...35,101,076
Ensembl chr17:35,081,580...35,117,241
|
|
G |
C6 |
complement component 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:4,756,550...4,833,527
Ensembl chr15:4,756,657...4,844,449
|
|
G |
Cabp1 |
calcium binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CABP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:115,306,750...115,332,440
Ensembl chr 5:115,306,748...115,332,440
|
|
G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNA1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:24,493,872...24,653,210
Ensembl chr 2:24,493,899...24,653,164
|
|
G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNA1G mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:94,299,217...94,365,226
Ensembl chr11:94,299,217...94,365,024
|
|
G |
Cacna1i |
calcium channel, voltage-dependent, alpha 1I subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNA1I mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:80,171,439...80,282,493
Ensembl chr15:80,171,439...80,282,480
|
|
G |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNA2D2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:107,276,948...107,406,545
Ensembl chr 9:107,276,811...107,406,542
|
|
G |
Cacng4 |
calcium channel, voltage-dependent, gamma subunit 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNG4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:107,623,183...107,685,532
Ensembl chr11:107,623,183...107,685,383
|
|
G |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNG7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:3,381,341...3,416,737
Ensembl chr 7:3,381,471...3,416,737
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CADM2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:66,452,302...67,417,825
Ensembl chr16:66,452,307...67,417,796
|
|
G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CALCA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
|
|
G |
Calhm3 |
calcium homeostasis modulator 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CALHM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:47,140,138...47,146,203
Ensembl chr19:47,140,048...47,146,203
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CAMK2N1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
|
|
G |
Camkv |
CaM kinase-like vesicle-associated |
increases expression |
ISO |
propionaldehyde results in increased expression of CAMKV mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:107,813,097...107,826,882
Ensembl chr 9:107,812,873...107,826,890
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CAMP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:109,676,445...109,678,524
Ensembl chr 9:109,676,447...109,678,685
|
|
G |
Camta1 |
calmodulin binding transcription activator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAMTA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:151,143,980...151,946,225
Ensembl chr 4:151,143,982...151,946,333
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:72,515,265...72,539,966
Ensembl chr 6:72,521,374...72,539,966
|
|
G |
Capn12 |
calpain 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPN12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:28,580,890...28,593,010
Ensembl chr 7:28,580,847...28,592,988
|
|
G |
Capn3 |
calpain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:120,294,074...120,335,400
Ensembl chr 2:120,294,053...120,335,399
|
|
G |
Car4 |
carbonic anhydrase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:84,848,580...84,856,880
Ensembl chr11:84,848,612...84,856,870
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CA9 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729
|
|
G |
Card9 |
caspase recruitment domain family, member 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of CARD9 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:26,242,199...26,250,957
Ensembl chr 2:26,242,188...26,250,930
|
|
G |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CARMN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:61,778,947...61,798,481
Ensembl chr18:61,782,325...61,799,611
|
|
G |
Carns1 |
carnosine synthase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CARNS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:4,214,323...4,227,390
Ensembl chr19:4,214,323...4,225,478
|
|
G |
Catsperz |
cation channel sperm associated auxiliary subunit zeta |
increases expression |
ISO |
propionaldehyde results in increased expression of CATSPERZ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:6,899,794...6,902,748
Ensembl chr19:6,899,739...6,902,748
|
|
G |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CC2D2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:40,737,197...40,818,227
Ensembl chr19:40,737,197...40,816,187
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCBE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:66,189,926...66,424,909
Ensembl chr18:66,178,373...66,435,812
|
|
G |
Ccdc103 |
coiled-coil domain containing 103 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:102,772,050...102,776,042
Ensembl chr11:102,772,030...102,776,042
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP263 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:96,260,684...96,285,516
Ensembl chr 8:96,260,713...96,285,518
|
|
G |
Ccdc121 |
coiled-coil domain containing 121 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC121 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:31,643,205...31,645,820
Ensembl chr 5:31,643,084...31,645,820
|
|
G |
Ccdc146 |
coiled-coil domain containing 146 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC146 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:21,496,749...21,629,675
Ensembl chr 5:21,497,959...21,629,675
|
|
G |
Ccdc148 |
coiled-coil domain containing 148 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC148 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:58,701,637...58,991,167
Ensembl chr 2:58,711,082...58,991,027
|
|
G |
Ccdc15 |
coiled-coil domain containing 15 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:37,178,758...37,262,508
Ensembl chr 9:37,187,131...37,259,728
|
|
G |
Ccdc153 |
coiled-coil domain containing 153 |
increases expression |
ISO |
propionaldehyde results in increased expression of DRC12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:44,151,961...44,158,240
Ensembl chr 9:44,151,973...44,158,603
|
|
G |
Ccdc160 |
coiled-coil domain containing 160 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC160 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:51,880,045...51,888,351
Ensembl chr X:51,880,077...51,888,345
|
|
G |
Ccdc169 |
coiled-coil domain containing 169 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC169 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:55,044,760...55,082,671
Ensembl chr 3:55,044,760...55,080,356
|
|
G |
Ccdc18 |
coiled-coil domain containing 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:108,280,583...108,388,378
Ensembl chr 5:108,280,741...108,381,494
|
|
G |
Ccdc28b |
coiled coil domain containing 28B |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC28B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:129,513,067...129,517,820
Ensembl chr 4:129,513,067...129,517,740
|
|
G |
Ccdc3 |
coiled-coil domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:5,142,587...5,235,682
Ensembl chr 2:5,142,587...5,235,689
|
|
G |
Ccdc30 |
coiled-coil domain containing 30 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC30 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,179,665...119,272,718
Ensembl chr 4:119,179,663...119,272,718
|
|
G |
Cck |
cholecystokinin |
increases expression |
ISO |
propionaldehyde results in increased expression of CCK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
|
|
G |
Ccl21a |
C-C motif chemokine ligand 21 (serine) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCL21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:42,772,860...42,773,991
Ensembl chr 4:42,772,860...42,773,993
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL26 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Ccm2l |
cerebral cavernous malformation 2-like |
increases expression |
ISO |
propionaldehyde results in increased expression of CCM2L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:152,907,857...152,923,655
Ensembl chr 2:152,907,875...152,923,655
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:54,609,306...54,617,158
Ensembl chr15:54,609,098...54,617,435
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:163,662,724...163,675,066
Ensembl chr 2:163,662,781...163,675,066
|
|
G |
Ccna1 |
cyclin A1 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CCNA1 gene |
CTD |
PMID:30002397 |
|
NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnb1ip1 |
cyclin B1 interacting protein 1 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CCNB1IP1 gene |
CTD |
PMID:30002397 |
|
NCBI chr14:51,026,706...51,033,185
Ensembl chr14:51,026,705...51,045,189
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCND2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNE2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:24,441,518...24,470,333
Ensembl chr17:24,441,172...24,470,458
|
|
G |
Cd22 |
CD22 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:30,564,829...30,579,767
Ensembl chr 7:30,564,827...30,579,767
|
|
G |
Cd33 |
CD33 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD33 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:43,176,823...43,186,679
Ensembl chr 7:43,173,640...43,193,852
|
|
G |
Cd40 |
CD40 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD40 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
increases expression |
ISO |
propionaldehyde results in increased expression of CD47 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:49,671,691...49,732,799
Ensembl chr16:49,620,896...49,735,373
|
|
G |
Cd52 |
CD52 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD52 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:133,820,849...133,822,384
Ensembl chr 4:133,809,759...133,822,393
|
|
G |
Cd55 |
CD55 molecule, decay accelerating factor for complement |
increases expression |
ISO |
propionaldehyde results in increased expression of CD55 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481
|
|
G |
Cd68 |
CD68 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD68 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
|
|
G |
Cd70 |
CD70 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD70 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:57,452,997...57,456,777
Ensembl chr17:57,452,997...57,456,777
|
|
G |
Cd79b |
CD79B antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD79B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
|
|
G |
Cd82 |
CD82 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD82 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:93,249,447...93,293,295
Ensembl chr 2:93,249,456...93,293,485
|
|
G |
Cd83 |
CD83 antigen |
increases expression |
ISO |
propionaldehyde results in increased expression of CD83 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
|
|
G |
Cd8a |
CD8 subunit alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CD8A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC25C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
|
|
G |
Cdc42bpg |
CDC42 binding protein kinase gamma |
increases expression |
ISO |
propionaldehyde results in increased expression of CDC42BPG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:6,356,465...6,375,682
Ensembl chr19:6,356,486...6,375,682
|
|
G |
Cdc45 |
cell division cycle 45 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC45 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:18,599,202...18,632,371
Ensembl chr16:18,599,197...18,630,737
|
|
G |
Cdca3 |
cell division cycle associated 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:124,806,533...124,810,664
Ensembl chr 6:124,806,510...124,810,664
|
|
G |
Cdca5 |
cell division cycle associated 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807
|
|
G |
Cdca8 |
cell division cycle associated 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDCP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:122,999,870...123,045,175
Ensembl chr 9:122,999,889...123,045,103
|
|
G |
Cdh15 |
cadherin 15 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDH15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:123,575,113...123,594,136
Ensembl chr 8:123,574,705...123,594,136
|
|
G |
Cdh16 |
cadherin 16 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDH16 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:105,328,547...105,351,028
Ensembl chr 8:105,328,543...105,351,028
|
|
G |
Cdh23 |
cadherin related 23 (otocadherin) |
increases expression |
ISO |
propionaldehyde results in increased expression of CDH23 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:60,138,527...60,532,291
Ensembl chr10:60,138,527...60,532,269
|
|
G |
Cdip1 |
cell death inducing Trp53 target 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDIP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:4,583,325...4,608,156
Ensembl chr16:4,568,212...4,608,156
|
|
G |
Cdiptos |
CDIP transferase, opposite strand |
increases expression |
ISO |
propionaldehyde results in increased expression of CDIPTOSP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:126,571,792...126,575,575
Ensembl chr 7:126,570,894...126,575,270
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk10 |
cyclin dependent kinase 10 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:123,951,580...123,958,995
Ensembl chr 8:123,951,581...123,958,989
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdkn2c |
cyclin dependent kinase inhibitor 2C |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDKN2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
|
|
G |
Cdnf |
cerebral dopamine neurotrophic factor |
increases expression |
ISO |
propionaldehyde results in increased expression of CDNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:3,514,102...3,527,413
Ensembl chr 2:3,514,067...3,527,413
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:101,913,001...101,971,724
Ensembl chr 5:101,912,996...101,971,724
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:123,294,754...123,299,869
Ensembl chr 8:123,294,754...123,300,293
|
|
G |
Cdyl2 |
chromodomain protein, Y chromosome-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDYL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:117,295,462...117,459,730
Ensembl chr 8:117,301,139...117,459,730
|
|
G |
Cecr2 |
CECR2, histone acetyl-lysine reader |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CECR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:120,643,275...120,748,152
Ensembl chr 6:120,643,330...120,748,151
|
|
G |
Celf4 |
CUGBP, Elav-like family member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CELF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:25,610,677...25,887,577
Ensembl chr18:25,610,689...25,887,214
|
|
G |
Celf5 |
CUGBP, Elav-like family member 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CELF5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:81,295,061...81,318,564
Ensembl chr10:81,295,061...81,318,543
|
|
G |
Cemip |
cell migration inducing protein, hyaluronan binding |
increases expression |
ISO |
propionaldehyde results in increased expression of CEMIP mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 7:83,582,065...83,735,893
Ensembl chr 7:83,582,065...83,735,710
|
|
G |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CEND1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:141,006,359...141,009,475
Ensembl chr 7:141,006,359...141,009,404
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283
|
|
G |
Cenph |
centromere protein H |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:100,896,187...100,912,415
Ensembl chr13:100,896,182...100,912,407
|
|
G |
Cenpi |
centromere protein I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:133,206,777...133,263,853
Ensembl chr X:133,208,833...133,263,388
|
|
G |
Cenpj |
centromere protein J |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPAP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:56,764,218...56,812,950
Ensembl chr14:56,764,218...56,812,882
|
|
G |
Cenpk |
centromere protein K |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:104,365,474...104,386,130
Ensembl chr13:104,365,119...104,388,900
|
|
G |
Cenpn |
centromere protein N |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:117,648,448...117,668,243
Ensembl chr 8:117,648,469...117,668,246
|
|
G |
Cenpo |
centromere protein O |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:4,243,548...4,284,255
Ensembl chr12:4,246,004...4,284,294
|
|
G |
Cenpp |
centromere protein P |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:49,617,501...49,806,457
Ensembl chr13:49,617,499...49,806,261
|
|
G |
Cep78 |
centrosomal protein 78 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CEP78 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:15,933,134...15,962,396
Ensembl chr19:15,933,137...15,962,353
|
|
G |
Cep85 |
centrosomal protein 85 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CEP85 gene |
CTD |
PMID:30002397 |
|
NCBI chr 4:133,857,169...133,914,420
Ensembl chr 4:133,857,169...133,914,423
|
|
G |
Cers1 |
ceramide synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CERS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:70,768,425...70,784,238
Ensembl chr 8:70,768,425...70,784,242
|
|
G |
Cetn4 |
centrin 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CETN4P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:37,362,776...37,366,595
Ensembl chr 3:37,361,898...37,366,857
|
|
G |
Cfap251 |
cilia and flagella associated protein 251 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP251 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:123,390,196...123,465,547
Ensembl chr 5:123,390,165...123,465,547
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP300 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:8,021,673...8,042,876
Ensembl chr 9:8,021,673...8,042,824
|
|
G |
Cfap43 |
cilia and flagella associated protein 43 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:47,723,706...47,825,893
Ensembl chr19:47,725,296...47,907,726
|
|
G |
Cfap52 |
cilia and flagella associated protein 52 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP52 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:67,815,632...67,856,494
Ensembl chr11:67,815,632...67,856,477
|
|
G |
Cfap58 |
cilia and flagella associated protein 58 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:47,926,151...48,023,818
Ensembl chr19:47,926,114...48,023,826
|
|
G |
Cfap70 |
cilia and flagella associated protein 70 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP70 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:20,444,258...20,502,332
Ensembl chr14:20,444,261...20,502,294
|
|
G |
Cfap74 |
cilia and flagella associated protein 74 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFAP74 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:155,493,647...155,551,280
Ensembl chr 4:155,493,647...155,551,280
|
|
G |
Cfap92 |
cilia and flagella associated protein 92 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP92 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:87,652,572...87,709,717
Ensembl chr 6:87,652,572...87,699,783
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
|
|
G |
Cfi |
complement component factor i |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:129,630,432...129,668,978
Ensembl chr 3:129,629,533...129,668,981
|
|
G |
Cga |
glycoprotein hormones, alpha subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of CGA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370
|
|
G |
Cgn |
cingulin |
increases expression |
ISO |
propionaldehyde results in increased expression of CGN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:94,667,376...94,695,036
Ensembl chr 3:94,667,376...94,693,826
|
|
G |
Cgnl1 |
cingulin-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CGNL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:71,533,789...71,716,582
Ensembl chr 9:71,533,791...71,678,884
|
|
G |
Chac1 |
ChaC, cation transport regulator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHCHD10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:75,768,964...75,773,584
Ensembl chr10:75,768,964...75,773,581
|
|
G |
Chd3 |
chromodomain helicase DNA binding protein 3 |
decreases expression increases methylation |
ISO |
propionaldehyde results in decreased expression of CHD3 mRNA propionaldehyde results in increased methylation of CHD3 gene |
CTD |
PMID:26079696 PMID:30002397 |
|
NCBI chr11:69,234,099...69,260,325
Ensembl chr11:69,234,099...69,260,232
|
|
G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHD5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:152,423,103...152,474,651
Ensembl chr 4:152,423,108...152,474,651
|
|
G |
Chit1 |
chitinase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHIT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:134,038,980...134,079,279
Ensembl chr 1:134,038,980...134,079,278
|
|
G |
Chrac1 |
chromatin accessibility complex 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:72,962,261...72,965,924
Ensembl chr15:72,962,241...72,969,403
|
|
G |
Chrdl2 |
chordin-like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRDL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:99,655,611...99,683,935
Ensembl chr 7:99,655,379...99,683,935
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
|
|
G |
Chrna3 |
cholinergic receptor, nicotinic, alpha polypeptide 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRNA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
|
|
G |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRNA7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317
|
|
G |
Chrnb4 |
cholinergic receptor, nicotinic, beta polypeptide 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRNB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063
|
|
G |
Chst1 |
carbohydrate sulfotransferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:92,429,978...92,445,597
Ensembl chr 2:92,430,052...92,445,595
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,820,274...83,031,738
Ensembl chr10:82,821,332...83,031,734
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:95,282,979...95,289,323
Ensembl chr 9:95,281,345...95,288,775
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:112,615,767...112,636,831
Ensembl chr 8:112,615,768...112,637,079
|
|
G |
Cib4 |
calcium and integrin binding family member 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:30,642,927...30,703,191
Ensembl chr 5:30,642,927...30,703,180
|
|
G |
Cibar2 |
CBY1 interacting BAR domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CIBAR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:120,893,136...120,904,225
Ensembl chr 8:120,893,136...120,904,205
|
|
G |
Cideb |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIDEB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:55,991,509...55,995,881
Ensembl chr14:55,991,507...55,995,915
|
|
G |
Cimip6 |
ciliary microtubule inner protein 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of CIMIP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:30,376,006...30,421,829
Ensembl chr11:30,376,006...30,421,827
|
|
G |
Cip2a |
cell proliferation regulating inhibitor of protein phosphatase 2A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIP2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:48,814,524...48,840,079
Ensembl chr16:48,814,548...48,840,072
|
|
G |
Cit |
citron |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:115,983,284...116,147,012
Ensembl chr 5:115,983,337...116,147,006
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CITED1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:101,290,984...101,295,787
Ensembl chr X:101,290,987...101,295,787
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CITED4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:120,523,760...120,525,017
Ensembl chr 4:120,523,769...120,525,017
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CKAP2L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:129,110,130...129,139,148
Ensembl chr 2:129,110,130...129,139,132
|
|
G |
Ckb |
creatine kinase, brain |
increases expression |
ISO |
propionaldehyde results in increased expression of CKB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
|
|
G |
Cks1b |
CDC28 protein kinase 1b |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CKS1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:89,322,779...89,325,598
Ensembl chr 3:89,322,779...89,325,690
|
|
G |
Clcn4 |
chloride channel, voltage-sensitive 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLCN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:7,285,308...7,303,837
Ensembl chr 7:7,285,308...7,303,850
|
|
G |
Cldn22 |
claudin 22 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CLDN22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:48,277,501...48,278,511
Ensembl chr 8:48,277,517...48,278,511
|
|
G |
Cldn3 |
claudin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLDN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326
|
|
G |
Cldn4 |
claudin 4 |
increases expression decreases expression |
ISO |
propionaldehyde results in increased expression of CLDN4 mRNA propionaldehyde results in decreased expression of CLDN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
|
|
G |
Clic3 |
chloride intracellular channel 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLIC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:25,346,855...25,348,789
Ensembl chr 2:25,346,850...25,348,788
|
|
G |
Clmp |
CXADR-like membrane protein |
increases expression |
ISO |
propionaldehyde results in increased expression of CLMP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:40,596,975...40,696,849
Ensembl chr 9:40,597,258...40,696,615
|
|
G |
Clrn3 |
clarin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CLRN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:135,113,185...135,130,383
Ensembl chr 7:135,113,195...135,130,383
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
increases expression |
ISO |
propionaldehyde results in increased expression of CLTRN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:162,873,183...162,901,855
Ensembl chr X:162,871,826...162,901,856
|
|
G |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNIH2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:5,142,896...5,148,549
Ensembl chr19:5,142,896...5,148,549
|
|
G |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNIH3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:181,178,024...181,288,059
Ensembl chr 1:181,180,193...181,288,206
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:22,010,501...22,020,517
Ensembl chr 9:22,010,512...22,020,926
|
|
G |
Cnn2 |
calponin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,824,434...79,831,234
Ensembl chr10:79,824,418...79,831,896
|
|
G |
Cobl |
cordon-bleu WH2 repeat |
increases expression |
ISO |
propionaldehyde results in increased expression of COBL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:12,186,676...12,415,022
Ensembl chr11:12,186,608...12,414,960
|
|
G |
Col13a1 |
collagen, type XIII, alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COL13A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:61,674,013...61,814,985
Ensembl chr10:61,674,015...61,814,887
|
|
G |
Col16a1 |
collagen, type XVI, alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COL16A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:129,941,638...129,993,070
Ensembl chr 4:129,941,633...129,993,076
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COL1A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col26a1 |
collagen, type XXVI, alpha 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COL26A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:136,770,613...136,912,230
Ensembl chr 5:136,770,613...136,912,063
|
|
G |
Col28a1 |
collagen, type XXVIII, alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COL28A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:7,997,100...8,193,709
Ensembl chr 6:7,997,808...8,192,617
|
|
G |
Col5a1 |
collagen, type V, alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COL5A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
|
|
G |
Col6a2 |
collagen, type VI, alpha 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of COL6A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
|
|
G |
Colec12 |
collectin sub-family member 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of COLEC12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644
|
|
G |
Coro6 |
coronin 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of CORO6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:77,353,149...77,361,310
Ensembl chr11:77,353,237...77,361,310
|
|
G |
Cotl1 |
coactosin like F-actin binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COTL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:120,535,953...120,567,318
Ensembl chr 8:120,535,961...120,567,283
|
|
G |
Cox17 |
cytochrome c oxidase assembly protein 17, copper chaperone |
increases methylation |
ISO |
propionaldehyde results in increased methylation of COX17 gene |
CTD |
PMID:30002397 |
|
NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COX6A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:127,804,607...127,805,538
Ensembl chr 7:127,804,607...127,805,559
|
|
G |
Cox8c |
cytochrome c oxidase subunit 8C |
increases expression |
ISO |
propionaldehyde results in increased expression of COX8C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:102,865,565...102,866,793
Ensembl chr12:102,865,575...102,866,785
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
|
|
G |
Cpa4 |
carboxypeptidase A4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CPA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:30,568,368...30,592,417
Ensembl chr 6:30,568,368...30,592,417
|
|
G |
Cplx2 |
complexin 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPLX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:54,455,447...54,531,736
Ensembl chr13:54,519,162...54,531,730
|
|
G |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:43,944,746...43,974,990
Ensembl chr19:43,944,746...43,974,995
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
ISO |
propionaldehyde results in decreased expression of PGCP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
ISO |
propionaldehyde results in increased expression of CPT1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:44,607,907...44,624,304
Ensembl chr 7:44,608,796...44,624,275
|
|
G |
Cpxm2 |
carboxypeptidase X, M14 family member 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPXM2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:131,634,416...131,756,483
Ensembl chr 7:131,634,416...131,756,468
|
|
G |
Crabp1 |
cellular retinoic acid binding protein I |
increases expression |
ISO |
propionaldehyde results in increased expression of CRABP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:54,672,032...54,680,394
Ensembl chr 9:54,672,032...54,680,394
|
|
G |
Crabp2 |
cellular retinoic acid binding protein II |
increases expression |
ISO |
propionaldehyde results in increased expression of CRABP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683
|
|
G |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
increases expression |
ISO |
propionaldehyde results in increased expression of CRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:139,101,288...139,307,262
Ensembl chr 1:139,124,794...139,304,838
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CREB3L3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:80,920,163...80,934,706
Ensembl chr10:80,920,158...80,934,708
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CREBBP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CRHR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
|
|
G |
Crip2 |
cysteine rich protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRIP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:113,103,856...113,109,126
Ensembl chr12:113,103,856...113,109,126
|
|
G |
Crip3 |
cysteine-rich protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRIP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:46,735,058...46,742,706
Ensembl chr17:46,739,852...46,742,702
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRLF1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:70,945,798...70,956,728
Ensembl chr 8:70,945,808...70,956,731
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRTAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:42,271,474...42,421,405
Ensembl chr19:42,256,726...42,420,224
|
|
G |
Crx |
cone-rod homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CRX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:15,599,872...15,613,880
Ensembl chr 7:15,599,872...15,613,893
|
|
G |
Crybg1 |
crystallin beta-gamma domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYBG1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:43,826,303...44,024,824
Ensembl chr10:43,826,632...44,024,849
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYBG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:133,788,042...133,819,815
Ensembl chr 4:133,788,126...133,819,815
|
|
G |
Crym |
crystallin, mu |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:119,785,603...119,801,212
Ensembl chr 7:119,785,603...119,801,334
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF1R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF2RA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:61,205,629...61,221,141
Ensembl chr19:61,212,395...61,216,867
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CSRP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970
|
|
G |
Csta2 |
cystatin A family member 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CSTA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:36,041,932...36,077,813
Ensembl chr16:36,041,838...36,077,810
|
|
G |
Ctdsp1 |
CTD small phosphatase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CTDSP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:74,430,625...74,436,444
Ensembl chr 1:74,430,668...74,436,444
|
|
G |
Cthrc1 |
collagen triple helix repeat containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CTHRC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:38,940,327...38,950,516
Ensembl chr15:38,940,327...38,950,516
|
|
G |
Ctnnd2 |
catenin delta 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CTNND2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:30,172,680...31,029,490
Ensembl chr15:30,172,739...31,029,487
|
|
G |
Ctps1 |
cytidine 5'-triphosphate synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CTPS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:120,397,065...120,427,473
Ensembl chr 4:120,397,065...120,427,473
|
|
G |
Ctsh |
cathepsin H |
increases expression |
ISO |
propionaldehyde results in increased expression of CTSH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:89,936,320...89,958,148
Ensembl chr 9:89,936,205...89,958,142
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CXCL12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
increases expression increases secretion |
ISO |
propionaldehyde results in increased expression of CXCL8 mRNA propionaldehyde results in increased secretion of CXCL8 protein |
CTD |
PMID:26079696 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl17 |
C-X-C motif chemokine ligand 17 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:25,099,478...25,112,311
Ensembl chr 7:25,099,478...25,112,311
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCR4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
|
|
G |
Cyb561 |
cytochrome b-561 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB561 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:105,824,528...105,844,157
Ensembl chr11:105,824,528...105,844,162
|
|
G |
Cyb5r1 |
cytochrome b5 reductase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB5R1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:134,333,519...134,339,476
Ensembl chr 1:134,333,297...134,339,478
|
|
G |
Cyb5r2 |
cytochrome b5 reductase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB5R2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:107,347,653...107,357,407
Ensembl chr 7:107,347,662...107,357,239
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYFIP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:46,084,676...46,203,686
Ensembl chr11:46,084,677...46,203,686
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP1A1 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP26A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984
|
|
G |
Cyp2c52-ps |
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP2C18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYP2C9 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2g1 |
cytochrome P450, family 2, subfamily g, polypeptide 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYP2G1P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:26,508,352...26,520,622
Ensembl chr 7:26,508,317...26,520,630
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP2J2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
increases expression |
ISO |
propionaldehyde results in increased expression of CYRIA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:12,312,136...12,430,966
Ensembl chr12:12,312,140...12,430,966
|
|
G |
Cysrt1 |
cysteine rich tail 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYSRT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:25,128,831...25,129,876
Ensembl chr 2:25,128,830...25,132,464
|
|
G |
Cyth4 |
cytohesin 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYTH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:78,481,247...78,506,219
Ensembl chr15:78,481,247...78,506,219
|
|
G |
Cytip |
cytohesin 1 interacting protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYTIP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:58,019,151...58,085,559
Ensembl chr 2:58,019,149...58,085,544
|
|
G |
D130043K22Rik |
RIKEN cDNA D130043K22 gene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of KIAA0319 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:25,029,114...25,085,422
Ensembl chr13:25,029,118...25,085,253
|
|
G |
D430041D05Rik |
RIKEN cDNA D430041D05 gene |
increases expression |
ISO |
propionaldehyde results in increased expression of KIAA1549L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:103,973,418...104,242,595
Ensembl chr 2:103,973,418...104,241,358
|
|
G |
D630039A03Rik |
RIKEN cDNA D630039A03 gene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C9ORF152 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:57,908,384...57,916,264
Ensembl chr 4:57,908,483...57,916,297
|
|
G |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
increases expression |
ISO |
propionaldehyde results in increased expression of C10ORF90 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:133,867,509...134,121,888
Ensembl chr 7:133,867,508...134,102,889
|
|
G |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DACT3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:16,609,242...16,621,226
Ensembl chr 7:16,609,242...16,621,387
|
|
G |
Dapl1 |
death associated protein-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DAPL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:59,314,997...59,335,364
Ensembl chr 2:59,314,997...59,335,364
|
|
G |
Daw1 |
dynein assembly factor with WDR repeat domains 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DAW1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:83,136,610...83,188,298
Ensembl chr 1:83,137,473...83,188,295
|
|
G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DCBLD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:58,228,789...58,304,013
Ensembl chr16:58,228,806...58,290,090
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DCLK1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:55,149,724...55,446,489
Ensembl chr 3:55,149,785...55,446,489
|
|
G |
Dcst2 |
DC-STAMP domain containing 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DCST2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:89,257,724...89,284,950
Ensembl chr 3:89,269,282...89,284,856
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DDC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
|
|
G |
Ddo |
D-aspartate oxidase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DDO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:40,505,933...40,557,847
Ensembl chr10:40,506,007...40,557,843
|
|
G |
Defb23 |
defensin beta 23 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEFB129 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:152,300,914...152,306,540
Ensembl chr 2:152,300,975...152,306,540
|
|
G |
Dennd1c |
DENN domain containing 1C |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:57,373,051...57,385,518
Ensembl chr17:57,372,905...57,385,514
|
|
G |
Dennd2c |
DENN domain containing 2C |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:103,009,954...103,077,054
Ensembl chr 3:103,009,920...103,077,085
|
|
G |
Dennd2d |
DENN domain containing 2D |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND2D mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:106,389,745...106,410,346
Ensembl chr 3:106,389,721...106,410,346
|
|
G |
Depdc1a |
DEP domain containing 1a |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEPDC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:159,201,042...159,235,690
Ensembl chr 3:159,201,070...159,235,592
|
|
G |
Depdc1b |
DEP domain containing 1B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEPDC1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:108,452,592...108,526,100
Ensembl chr13:108,452,866...108,544,316
|
|
G |
Dgka |
diacylglycerol kinase, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of DGKA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:128,556,000...128,581,002
Ensembl chr10:128,556,003...128,580,724
|
|
G |
Dhdh |
dihydrodiol dehydrogenase |
increases expression |
ISO |
propionaldehyde results in increased expression of DHDH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:45,122,380...45,138,312
Ensembl chr 7:45,120,411...45,138,229
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DHFR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
|
|
G |
Dhrs2 |
dehydrogenase/reductase member 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHRS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:55,459,464...55,478,897
Ensembl chr14:55,459,464...55,478,892
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHRS9 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 2:69,210,806...69,233,430
Ensembl chr 2:69,210,789...69,234,877
|
|
G |
Dhx58 |
DExH-box helicase 58 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHX58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:100,585,710...100,595,165
Ensembl chr11:100,585,710...100,595,097
|
|
G |
Diaph3 |
diaphanous related formin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DIAPH3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:86,892,793...87,378,683
Ensembl chr14:86,892,803...87,378,671
|
|
G |
Dipk1b |
divergent protein kinase domain 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of DIPK1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:26,518,469...26,526,509
Ensembl chr 2:26,518,469...26,526,509
|
|
G |
Diras1 |
DIRAS family, GTP-binding RAS-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DIRAS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:80,855,423...80,862,038
Ensembl chr10:80,855,423...80,861,496
|
|
G |
Disc1 |
disrupted in schizophrenia 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DISC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:125,773,928...125,991,882
Ensembl chr 8:125,780,934...125,988,597
|
|
G |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DKK3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:111,715,226...111,758,689
Ensembl chr 7:111,715,224...111,758,264
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DLL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:15,587,616...15,597,275
Ensembl chr17:15,587,616...15,597,134
|
|
G |
Dlx2 |
distal-less homeobox 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DLX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:71,373,752...71,377,095
Ensembl chr 2:71,373,752...71,377,098
|
|
G |
Dmd |
dystrophin, muscular dystrophy |
increases expression |
ISO |
propionaldehyde results in increased expression of DMD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:81,858,244...84,248,656
Ensembl chr X:81,992,476...84,249,747
|
|
G |
Dmkn |
dermokine |
increases expression |
ISO |
propionaldehyde results in increased expression of DMKN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:30,463,181...30,480,491
Ensembl chr 7:30,463,181...30,480,488
|
|
G |
Dnaaf11 |
dynein axonemal assembly factor 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:66,251,707...66,372,769
Ensembl chr15:66,251,707...66,372,759
|
|
G |
Dnaaf2 |
dynein, axonemal assembly factor 2 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of DNAAF2 gene |
CTD |
PMID:30002397 |
|
NCBI chr12:69,235,861...69,245,203
Ensembl chr12:69,235,861...69,245,203
|
|
G |
Dnaaf3 |
dynein, axonemal assembly factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:4,525,932...4,535,487
Ensembl chr 7:4,525,932...4,535,452
|
|
G |
Dnah10 |
dynein, axonemal, heavy chain 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:124,802,149...124,911,372
Ensembl chr 5:124,802,149...124,911,372
|
|
G |
Dnah12 |
dynein, axonemal, heavy chain 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:26,412,709...26,614,250
Ensembl chr14:26,414,429...26,613,660
|
|
G |
Dnah7b |
dynein, axonemal, heavy chain 7B |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:46,105,232...46,412,711
Ensembl chr 1:46,105,475...46,412,710
|
|
G |
Dnai1 |
dynein axonemal intermediate chain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:41,569,731...41,638,158
Ensembl chr 4:41,569,775...41,638,158
|
|
G |
Dnai3 |
dynein axonemal intermediate chain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:145,746,281...145,813,855
Ensembl chr 3:145,746,281...145,813,885
|
|
G |
Dnai4 |
dynein axonemal intermediate chain 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:102,891,954...102,971,524
Ensembl chr 4:102,895,262...102,971,752
|
|
G |
Dnai7 |
dynein axonemal intermediate chain 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:145,120,556...145,156,866
Ensembl chr 6:145,120,560...145,156,731
|
|
G |
Dnajc5b |
DnaJ heat shock protein family (Hsp40) member C5 beta |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAJC5B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:19,562,755...19,665,026
Ensembl chr 3:19,562,759...19,665,026
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
propionaldehyde results in increased expression of DNER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:84,347,560...84,673,942
Ensembl chr 1:84,347,560...84,673,942
|
|
G |
Dnm3 |
dynamin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:161,810,022...162,305,890
Ensembl chr 1:161,810,022...162,305,603
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DOCK4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:40,495,956...40,896,873
Ensembl chr12:40,495,951...40,896,873
|
|
G |
Dock5 |
dedicator of cytokinesis 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of DOCK5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:67,989,377...68,171,021
Ensembl chr14:67,989,584...68,170,891
|
|
G |
Dpep1 |
dipeptidase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DPEP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:123,913,069...123,928,551
Ensembl chr 8:123,912,981...123,928,551
|
|
G |
Dpep3 |
dipeptidase 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DPEP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:106,700,152...106,706,051
Ensembl chr 8:106,700,145...106,706,061
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DPP4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
increases expression |
ISO |
propionaldehyde results in increased expression of DPYD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
|
|
G |
Dpysl5 |
dihydropyrimidinase-like 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of DPYSL5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:30,868,908...30,956,713
Ensembl chr 5:30,868,908...30,956,719
|
|
G |
Drd3 |
dopamine receptor D3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DRD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
|
|
G |
Drgx |
dorsal root ganglia homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DRGX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:32,317,824...32,371,203
Ensembl chr14:32,321,364...32,371,203
|
|
G |
Dscaml1 |
DS cell adhesion molecule like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSCAML1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:45,338,735...45,665,011
Ensembl chr 9:45,337,926...45,665,010
|
|
G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSCC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:54,939,497...54,953,887
Ensembl chr15:54,939,495...54,953,887
|
|
G |
Dsn1 |
DSN1 homolog, MIS12 kinetochore complex component |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:156,836,982...156,848,995
Ensembl chr 2:156,837,185...156,849,074
|
|
G |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
increases expression |
ISO |
propionaldehyde results in increased expression of DTX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:120,818,268...120,850,879
Ensembl chr 5:120,818,267...120,849,992
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP26 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:31,579,555...31,587,074
Ensembl chr 8:31,579,499...31,587,075
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
|
|
G |
Dydc2 |
DPY30 domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DYDC2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:40,770,573...40,795,014
Ensembl chr14:40,771,074...40,791,165
|
|
G |
E2f7 |
E2F transcription factor 7 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of E2F7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:110,580,799...110,623,245
Ensembl chr10:110,581,300...110,623,245
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of E2F8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344
|
|
G |
Ebi3 |
Epstein-Barr virus induced gene 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EBI3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:56,259,623...56,264,022
Ensembl chr17:56,259,640...56,264,022
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ECM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881
|
|
G |
Edn2 |
endothelin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EDN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557
|
|
G |
Edn3 |
endothelin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EDN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:174,602,412...174,625,835
Ensembl chr 2:174,602,412...174,625,835
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EEF1A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:180,783,551...180,798,808
Ensembl chr 2:180,789,446...180,798,807
|
|
G |
Efcab10 |
EF-hand calcium binding domain 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFCAB10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:33,444,824...33,451,268
Ensembl chr12:33,444,853...33,451,266
|
|
G |
Efcab11 |
EF-hand calcium binding domain 11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EFCAB11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:99,683,790...99,849,701
Ensembl chr12:99,659,304...99,850,698
|
|
G |
Efcab2 |
EF-hand calcium binding domain 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EFCAB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:178,233,583...178,312,078
Ensembl chr 1:178,233,650...178,312,078
|
|
G |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFEMP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743
|
|
G |
Efhd1 |
EF hand domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFHD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:87,192,075...87,238,563
Ensembl chr 1:87,192,085...87,238,561
|
|
G |
Efnb2 |
ephrin B2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFNB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242
|
|
G |
Efnb3 |
ephrin B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFNB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:69,444,918...69,452,428
Ensembl chr11:69,444,918...69,451,031
|
|
G |
Efr3b |
EFR3 homolog B |
increases expression |
ISO |
propionaldehyde results in increased expression of EFR3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:4,012,554...4,089,199
Ensembl chr12:4,012,554...4,088,915
|
|
G |
Egfem1 |
EGF-like and EMI domain containing 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EGFEM1P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:29,135,695...29,831,923
Ensembl chr 3:29,136,172...29,745,358
|
|
G |
Egr2 |
early growth response 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EGR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELAPOR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:108,362,995...108,444,064
Ensembl chr 3:108,363,010...108,443,852
|
|
G |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELFN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:78,551,531...78,603,056
Ensembl chr15:78,551,531...78,602,971
|
|
G |
Elmod1 |
ELMO/CED-12 domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELMOD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:53,818,741...53,882,628
Ensembl chr 9:53,818,741...53,882,585
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELOVL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:46,120,336...46,124,133
Ensembl chr19:46,120,336...46,124,133
|
|
G |
Elovl4 |
ELOVL fatty acid elongase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELOVL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:83,660,745...83,688,358
Ensembl chr 9:83,660,745...83,688,330
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EME1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:94,535,798...94,544,611
Ensembl chr11:94,535,822...94,544,790
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EMP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171
|
|
G |
Enho |
energy homeostasis associated |
increases expression |
ISO |
propionaldehyde results in increased expression of ENHO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:41,638,144...41,640,302
Ensembl chr 4:41,638,144...41,640,324
|
|
G |
Eno2 |
enolase 2, gamma neuronal |
increases expression |
ISO |
propionaldehyde results in increased expression of ENO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
|
|
G |
Eno3 |
enolase 3, beta muscle |
increases expression |
ISO |
propionaldehyde results in increased expression of ENO3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:70,543,973...70,553,339
Ensembl chr11:70,548,028...70,553,339
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENOX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:77,393,790...77,959,203
Ensembl chr14:77,394,203...77,959,200
|
|
G |
Entrep1 |
endosomal transmembrane epsin interactor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENTREP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:23,950,114...24,008,800
Ensembl chr19:23,950,114...24,008,383
|
|
G |
Eomes |
eomesodermin |
increases expression |
ISO |
propionaldehyde results in increased expression of EOMES mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:118,307,259...118,315,176
Ensembl chr 9:118,307,280...118,315,200
|
|
G |
Epc2 |
enhancer of polycomb homolog 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EPC2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:49,341,498...49,441,954
Ensembl chr 2:49,341,498...49,441,960
|
|
G |
Epcip |
exosomal polycystin 1 interacting protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EPCIP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:90,841,534...90,866,040
Ensembl chr16:90,850,823...90,892,010
|
|
G |
Epha10 |
Eph receptor A10 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHA10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:124,775,408...124,811,594
Ensembl chr 4:124,774,692...124,811,593
|
|
G |
Epha2 |
Eph receptor A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:141,028,532...141,056,695
Ensembl chr 4:141,028,551...141,056,695
|
|
G |
Ephb2 |
Eph receptor B2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299
|
|
G |
Ephb3 |
Eph receptor B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:21,023,530...21,042,054
Ensembl chr16:21,023,505...21,042,055
|
|
G |
Epn3 |
epsin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:94,380,425...94,390,800
Ensembl chr11:94,380,425...94,390,800
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
propionaldehyde results in increased expression of EREG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ERGIC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:26,779,736...26,875,908
Ensembl chr17:26,780,463...26,875,908
|
|
G |
Erich4 |
glutamate rich 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERICH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:25,314,045...25,315,278
Ensembl chr 7:25,314,045...25,315,317
|
|
G |
Ermap |
erythroblast membrane-associated protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERMAP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,032,654...119,047,210
Ensembl chr 4:119,032,654...119,047,208
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERP27 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:136,884,312...136,899,465
Ensembl chr 6:136,884,309...136,899,178
|
|
G |
Esam |
endothelial cell-specific adhesion molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of ESAM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:37,439,385...37,449,615
Ensembl chr 9:37,439,374...37,449,615
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ESCO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:66,056,476...66,071,418
Ensembl chr14:66,056,487...66,071,443
|
|
G |
Espl1 |
extra spindle pole bodies 1, separase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ESPL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:102,204,688...102,232,792
Ensembl chr15:102,204,701...102,232,792
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ETNK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:133,291,308...133,308,056
Ensembl chr 1:133,291,310...133,308,074
|
|
G |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ETS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095
|
|
G |
Evi5l |
ecotropic viral integration site 5 like |
increases expression |
ISO |
propionaldehyde results in increased expression of EVI5L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:4,216,523...4,258,089
Ensembl chr 8:4,216,567...4,261,257
|
|
G |
Exoc3l4 |
exocyst complex component 3-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of EXOC3L4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:111,383,864...111,398,114
Ensembl chr12:111,383,451...111,398,112
|
|
G |
Exosc8 |
exosome component 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EXOSC8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:54,636,099...54,642,469
Ensembl chr 3:54,636,099...54,642,814
|
|
G |
Exph5 |
exophilin 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of EXPH5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:53,212,814...53,292,466
Ensembl chr 9:53,212,970...53,288,814
|
|
G |
F13b |
coagulation factor XIII, beta subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F13B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:139,429,285...139,451,496
Ensembl chr 1:139,429,440...139,451,490
|
|
G |
F2 |
coagulation factor II |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
|
|
G |
F2r |
coagulation factor II thrombin receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of F2R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
|
|
G |
F5 |
coagulation factor V |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
|
|
G |
F7 |
coagulation factor VII |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
|
|
G |
Fa2h |
fatty acid 2-hydroxylase |
increases expression |
ISO |
propionaldehyde results in increased expression of FA2H mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:112,071,770...112,120,453
Ensembl chr 8:112,071,767...112,120,456
|
|
G |
Faap24 |
Fanconi anemia core complex associated protein 24 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAAP24 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:35,091,577...35,096,192
Ensembl chr 7:35,091,577...35,096,261
|
|
G |
Fabp6 |
fatty acid binding protein 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of FABP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:43,486,867...43,492,389
Ensembl chr11:43,486,876...43,492,367
|
|
G |
Fam110a |
family with sequence similarity 110, member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAM110A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:151,811,318...151,822,096
Ensembl chr 2:151,811,318...151,822,139
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAM13A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:58,910,521...59,001,487
Ensembl chr 6:58,909,075...59,001,534
|
|
G |
Fam184a |
family with sequence similarity 184, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM184A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:53,509,131...53,627,368
Ensembl chr10:53,509,241...53,627,219
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM25A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:34,073,842...34,080,296
Ensembl chr14:34,073,838...34,077,390
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM43A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:30,418,541...30,421,615
Ensembl chr16:30,418,541...30,421,615
|
|
G |
Fam43b |
family with sequence similarity 43, member B |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM43B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:138,121,403...138,123,769
Ensembl chr 4:138,121,403...138,123,839
|
|
G |
Fam90a1b |
family with sequence similarity 90, member A1B |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM90A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:93,383,509...93,410,513
Ensembl chr X:93,398,659...93,410,383 Ensembl chr X:93,398,659...93,410,383
|
|
G |
Fancd2 |
Fanconi anemia, complementation group D2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FANCD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:113,508,622...113,573,981
Ensembl chr 6:113,508,643...113,573,978
|
|
G |
Fanci |
Fanconi anemia, complementation group I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FANCI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of FAS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasl |
Fas ligand |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FASLG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fblim1 |
filamin binding LIM protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLIM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:141,303,373...141,333,351
Ensembl chr 4:141,303,373...141,333,407
|
|
G |
Fbln2 |
fibulin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:91,189,442...91,249,522
Ensembl chr 6:91,189,437...91,249,522
|
|
G |
Fbln5 |
fibulin 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:58,141,689...58,343,200
Ensembl chr18:58,141,695...58,343,559
|
|
G |
Fbxo2 |
F-box protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBXO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:148,244,605...148,250,874
Ensembl chr 4:148,245,078...148,250,881
|
|
G |
Fbxo24 |
F-box protein 24 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO24 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:137,610,767...137,623,340
Ensembl chr 5:137,610,765...137,627,264
|
|
G |
Fbxo41 |
F-box protein 41 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBXO41 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:85,446,556...85,479,976
Ensembl chr 6:85,446,556...85,479,976
|
|
G |
Fbxo43 |
F-box protein 43 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:36,150,206...36,170,086
Ensembl chr15:36,150,206...36,165,030
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:5,749,155...5,755,465
Ensembl chr10:5,749,160...5,755,600
|
|
G |
Fbxw13 |
F-box and WD-40 domain protein 13 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXW12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:109,008,295...109,025,043
Ensembl chr 9:109,008,295...109,025,043
|
|
G |
Fcrl2 |
Fc receptor like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FCRL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:87,158,318...87,171,046
Ensembl chr 3:87,158,065...87,171,045
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
propionaldehyde results in increased expression of FDXR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:115,158,850...115,167,925
Ensembl chr11:115,158,850...115,167,876
|
|
G |
Fer1l6 |
fer-1 like family member 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FER1L6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:58,381,897...58,536,936
Ensembl chr15:58,381,897...58,536,941
|
|
G |
Fez1 |
fasciculation and elongation protein zeta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FEZ1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:36,732,694...36,790,220
Ensembl chr 9:36,733,160...36,790,220
|
|
G |
Ffar2 |
free fatty acid receptor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FFAR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:30,517,778...30,523,200
Ensembl chr 7:30,517,773...30,523,200
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
|
|
G |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:49,415,030...49,473,783
Ensembl chr13:49,415,030...49,473,787
|
|
G |
Fgf13 |
fibroblast growth factor 13 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGF13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:58,107,499...58,630,932
Ensembl chr X:58,107,505...58,613,431
|
|
G |
Fgf20 |
fibroblast growth factor 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGF20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:40,732,206...40,740,060
Ensembl chr 8:40,732,207...40,761,372
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGFBP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:44,136,200...44,139,173
Ensembl chr 5:44,136,200...44,139,121
|
|
G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGFBP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:36,894,950...36,896,999
Ensembl chr19:36,894,950...36,897,015
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
|
|
G |
Fgl1 |
fibrinogen-like protein 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:41,644,471...41,671,015
Ensembl chr 8:41,644,471...41,668,193
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FHL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FHOD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:24,841,445...25,266,564
Ensembl chr18:24,841,680...25,266,558
|
|
G |
Fignl1 |
fidgetin-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FIGNL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:11,737,429...11,758,962
Ensembl chr11:11,737,431...11,758,962
|
|
G |
Fkbp1b |
FK506 binding protein 1b |
increases expression |
ISO |
propionaldehyde results in increased expression of FKBP1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:4,883,174...4,891,736
Ensembl chr12:4,883,174...4,891,591
|
|
G |
Flcn |
folliculin |
increases expression |
ISO |
propionaldehyde results in increased expression of FLCN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:59,682,234...59,706,138
Ensembl chr11:59,682,234...59,700,842
|
|
G |
Flna |
filamin, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of FLNA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426
|
|
G |
Flywch1 |
FLYWCH-type zinc finger 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FLYWCH1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:23,971,767...23,993,504
Ensembl chr17:23,971,767...23,990,576
|
|
G |
Fmo4 |
flavin containing monooxygenase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FMO4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:162,620,757...162,643,788
Ensembl chr 1:162,620,757...162,641,541
|
|
G |
Fmo5 |
flavin containing monooxygenase 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FMO5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:97,517,248...97,562,603
Ensembl chr 3:97,536,120...97,562,598
|
|
G |
Fmod |
fibromodulin |
increases expression |
ISO |
propionaldehyde results in increased expression of FMOD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:133,964,992...133,976,018
Ensembl chr 1:133,964,992...133,976,015
|
|
G |
Fmr1os |
FMRP translational regulator 1, opposite strand |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FMR1-AS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:67,711,120...67,722,005
|
|
G |
Fn3k |
fructosamine 3 kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FN3K mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:121,325,779...121,341,316
Ensembl chr11:121,325,739...121,341,317
|
|
G |
Fndc11 |
fibronectin type III domain containing 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:180,854,385...180,864,649
Ensembl chr 2:180,861,806...180,864,647
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:27,470,284...27,765,469
Ensembl chr 3:27,470,311...27,765,456
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:129,030,672...129,038,386
Ensembl chr 4:129,030,477...129,038,386
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FOS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FOXM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
|
|
G |
Foxn4 |
forkhead box N4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FOXN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:114,392,225...114,412,486
Ensembl chr 5:114,392,225...114,411,868
|
|
G |
Fpr1 |
formyl peptide receptor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FPR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:18,096,733...18,104,201
Ensembl chr17:18,096,733...18,104,202
|
|
G |
Frat1 |
frequently rearranged in advanced T cell lymphomas |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRAT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:41,818,409...41,821,022
Ensembl chr19:41,818,409...41,821,022
|
|
G |
Frg2f1 |
FSHD region gene 2 family member 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRG2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,387,505...119,395,966
Ensembl chr 4:119,387,505...119,396,726
|
|
G |
Frmd4b |
FERM domain containing 4B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRMD4B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:97,263,828...97,594,618
Ensembl chr 6:97,263,828...97,594,502
|
|
G |
Frmd5 |
FERM domain containing 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRMD5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:121,376,010...121,637,580
Ensembl chr 2:121,376,010...121,637,568
|
|
G |
Frmd8 |
FERM domain containing 8 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRMD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:5,901,002...5,925,297
Ensembl chr19:5,899,730...5,925,302
|
|
G |
Frrs1 |
ferric-chelate reductase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRRS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:116,653,212...116,701,363
Ensembl chr 3:116,653,113...116,701,826
|
|
G |
Fry |
FRY microtubule binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRY mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:150,042,083...150,421,218
Ensembl chr 5:150,042,110...150,421,218
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO |
propionaldehyde results in increased expression of FRZB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:80,242,314...80,277,740
Ensembl chr 2:80,242,314...80,277,969
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSCN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:142,946,110...142,958,944
Ensembl chr 5:142,946,098...142,958,940
|
|
G |
Fstl3 |
follistatin-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSTL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,613,108...79,618,464
Ensembl chr10:79,613,106...79,618,464
|
|
G |
Fstl4 |
follistatin-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSTL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:52,655,320...53,083,277
Ensembl chr11:52,655,461...53,079,365
|
|
G |
Ftcd |
formiminotransferase cyclodeaminase |
increases expression |
ISO |
propionaldehyde results in increased expression of FTCD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:76,411,482...76,426,172
Ensembl chr10:76,411,482...76,426,172
|
|
G |
Fuom |
fucose mutarotase |
increases expression |
ISO |
propionaldehyde results in increased expression of FUOM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:139,677,724...139,684,745
Ensembl chr 7:139,676,683...139,682,354
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FXYD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:45,311,007...45,321,576
Ensembl chr 9:45,310,967...45,321,576
|
|
G |
Fxyd7 |
FXYD domain-containing ion transport regulator 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of FXYD7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:30,741,940...30,750,879
Ensembl chr 7:30,741,938...30,750,892
|
|
G |
Fyn |
Fyn proto-oncogene |
increases expression |
ISO |
propionaldehyde results in increased expression of FYN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
|
|
G |
Gab3 |
growth factor receptor bound protein 2-associated protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GAB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:74,032,151...74,128,511
Ensembl chr X:74,010,449...74,129,064
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GABBR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:46,662,318...46,991,714
Ensembl chr 4:46,662,305...46,991,873
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GAD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of GADD45A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
increases expression |
ISO |
propionaldehyde results in increased expression of GADD45G mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of GAL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:3,459,915...3,464,544
Ensembl chr19:3,459,915...3,464,544
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GAL3ST1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:3,933,636...3,949,328
Ensembl chr11:3,933,636...3,949,326
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:57,536,268...57,678,327
Ensembl chr11:57,536,268...57,678,340
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT16 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:80,565,245...80,650,672
Ensembl chr12:80,565,051...80,677,746
|
|
G |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:111,070,863...111,379,274
Ensembl chr 7:111,070,868...111,379,184
|
|
G |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:57,887,832...57,931,039
Ensembl chr 2:57,887,896...57,935,872
|
|
G |
Galnt6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:100,587,796...100,627,257
Ensembl chr15:100,589,694...100,627,257
|
|
G |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GALNTL6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:58,225,523...59,366,213
Ensembl chr 8:58,227,086...59,365,674
|
|
G |
Gamt |
guanidinoacetate methyltransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of GAMT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:80,093,985...80,096,846
Ensembl chr10:80,093,985...80,096,846
|
|
G |
Garin1b |
golgi associated RAB2 interactor 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of GARIN1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:29,313,468...29,336,021
Ensembl chr 6:29,319,139...29,336,018
|
|
G |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GARNL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:32,876,237...33,021,871
Ensembl chr 2:32,876,236...33,021,666
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GAS2L3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:89,244,684...89,279,935
Ensembl chr10:89,244,685...89,279,829
|
|
G |
Gata5 |
GATA binding protein 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GATA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:179,966,881...179,977,296
Ensembl chr 2:179,966,926...179,976,492
|
|
G |
Gbp2b |
guanylate binding protein 2b |
increases expression |
ISO |
propionaldehyde results in increased expression of GBP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GBX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,855,684...89,858,898
Ensembl chr 1:89,855,678...89,858,901
|
|
G |
Gcgr |
glucagon receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of GCGR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:120,420,011...120,429,815
Ensembl chr11:120,421,525...120,429,812
|
|
G |
Gckr |
glucokinase regulatory protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GCKR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:31,454,594...31,484,646
Ensembl chr 5:31,454,787...31,484,658
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GCLC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GCNT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208
|
|
G |
Gdf11 |
growth differentiation factor 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDF11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:128,716,393...128,727,587
Ensembl chr10:128,718,164...128,727,587
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDF15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
|
|
G |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDPD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:86,924,620...86,964,963
Ensembl chr11:86,924,693...86,964,888
|
|
G |
Gfi1 |
growth factor independent 1 transcription repressor |
increases expression |
ISO |
propionaldehyde results in increased expression of GFI1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:107,864,521...107,873,671
Ensembl chr 5:107,864,523...107,873,902
|
|
G |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GFOD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:43,348,716...43,457,648
Ensembl chr13:43,348,721...43,457,648
|
|
G |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GFRA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
|
|
G |
Gfra4 |
glial cell line derived neurotrophic factor family receptor alpha 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GFRA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:130,881,552...130,885,008
Ensembl chr 2:130,881,552...130,885,008
|
|
G |
Gins1 |
GINS complex subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GINS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:150,751,482...150,773,200
Ensembl chr 2:150,747,320...150,773,200
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GINS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:121,308,005...121,315,814
Ensembl chr 8:121,305,372...121,316,043
|
|
G |
Gja3 |
gap junction protein, alpha 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:57,271,917...57,295,487
Ensembl chr14:57,271,917...57,295,557
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GJB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:100,419,982...100,429,235
Ensembl chr X:100,419,984...100,429,235
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
|
|
G |
Gjb4 |
gap junction protein, beta 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:127,234,892...127,247,929
Ensembl chr 4:127,244,879...127,247,874
|
|
G |
Gjb5 |
gap junction protein, beta 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:127,248,600...127,251,957
Ensembl chr 4:127,248,602...127,251,974
|
|
G |
Gjd3 |
gap junction protein, delta 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:98,870,773...98,873,846
Ensembl chr11:98,873,006...98,873,842
|
|
G |
Gkn1 |
gastrokine 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GKN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:87,322,635...87,327,897
Ensembl chr 6:87,322,632...87,327,924
|
|
G |
Gkn2 |
gastrokine 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GKN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:87,350,347...87,356,476
Ensembl chr 6:87,350,339...87,356,479
|
|
G |
Gldc |
glycine decarboxylase |
increases expression |
ISO |
propionaldehyde results in increased expression of GLDC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:30,075,847...30,152,829
Ensembl chr19:30,075,847...30,152,829
|
|
G |
Glipr1 |
GLI pathogenesis related 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GLIPR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536
|
|
G |
Glipr2 |
GLI pathogenesis-related 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GLIPR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:43,957,702...43,979,118
Ensembl chr 4:43,957,401...43,979,118
|
|
G |
Glyctk |
glycerate kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GLYCTK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:106,030,058...106,037,353
Ensembl chr 9:106,030,056...106,035,337
|
|
G |
Gm13889 |
predicted gene 13889 |
increases expression |
ISO |
propionaldehyde results in increased expression of C11ORF96 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:93,786,155...93,787,445
Ensembl chr 2:93,786,155...93,787,546
|
|
G |
Gm22728 |
predicted gene, 22728 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of SCARNA23 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:92,203,923...92,204,051
Ensembl chr 5:92,203,923...92,204,051
|
|
G |
Gm26871 |
predicted gene, 26871 |
increases expression |
ISO |
propionaldehyde results in increased expression of MIR137HG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:118,223,583...118,337,636
Ensembl chr 3:118,223,745...118,328,662
|
|
G |
Gm2a |
GM2 ganglioside activator protein |
increases expression |
ISO |
propionaldehyde results in increased expression of GM2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:54,988,811...55,003,855
Ensembl chr11:54,988,941...55,003,855
|
|
G |
Gm32687 |
predicted gene, 32687 |
increases expression |
ISO |
propionaldehyde results in increased expression of ZNF284 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:81,699,690...81,716,920
Ensembl chr10:81,699,768...81,716,915
|
|
G |
Gm3443 |
predicted gene 3443 |
decreases methylation |
ISO |
propionaldehyde results in decreased methylation of C9ORF57 gene |
CTD |
PMID:30002397 |
|
NCBI chr19:21,529,597...21,535,231
Ensembl chr19:21,530,305...21,535,021
|
|
G |
Gm36566 |
predicted gene, 36566 |
increases expression |
ISO |
propionaldehyde results in increased expression of KLLN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:32,731,847...32,734,812
|
|
G |
Gm3764 |
predicted gene 3764 |
increases expression |
ISO |
propionaldehyde results in increased expression of MIR9-1HG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:88,113,980...88,137,266
Ensembl chr 3:88,113,033...88,137,271
|
|
G |
Gm38656 |
predicted gene, 38656 |
increases expression |
ISO |
propionaldehyde results in increased expression of SCGB1D2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:9,162,589...9,164,383
|
|
G |
Gm572 |
predicted gene 572 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1ORF127 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:148,727,774...148,761,562
Ensembl chr 4:148,727,774...148,760,753
|
|
G |
Gm6760 |
predicted gene 6760 |
increases expression |
ISO |
propionaldehyde results in increased expression of SPANXN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:63,195,011...63,195,804
Ensembl chr X:63,195,011...63,195,804
|
|
G |
Gm7030 |
predicted gene 7030 |
increases expression |
ISO |
propionaldehyde results in increased expression of HLA-F mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:36,438,501...36,440,317
Ensembl chr17:36,420,611...36,440,317
|
|
G |
Gm7298 |
predicted gene 7298 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPAMD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:121,711,454...121,761,598
Ensembl chr 6:121,709,891...121,766,043
|
|
G |
Gm7694 |
predicted gene 7694 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF226 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:170,125,767...170,133,901
Ensembl chr 1:170,125,768...170,133,901
|
|
G |
Gmpr |
guanosine monophosphate reductase |
increases expression |
ISO |
propionaldehyde results in increased expression of GMPR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:45,660,905...45,699,862
Ensembl chr13:45,660,920...45,707,276
|
|
G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
increases expression |
ISO |
propionaldehyde results in increased expression of GNAO1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:94,537,213...94,696,016
Ensembl chr 8:94,536,594...94,696,016
|
|
G |
Gnaz |
guanine nucleotide binding protein, alpha z subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of GNAZ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:74,803,009...74,852,739
Ensembl chr10:74,803,009...74,852,739
|
|
G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of GNG7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:80,784,463...80,850,742
Ensembl chr10:80,784,458...80,850,779
|
|
G |
Golga7b |
golgin A7B |
increases expression |
ISO |
propionaldehyde results in increased expression of GOLGA7B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:42,236,017...42,258,787
Ensembl chr19:42,236,013...42,258,787
|
|
G |
Gpr143 |
G protein-coupled receptor 143 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR143 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:151,564,917...151,591,647
Ensembl chr X:151,564,917...151,591,642
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPR146 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:139,363,452...139,382,170
Ensembl chr 5:139,363,452...139,382,170
|
|
G |
Gpr155 |
G protein-coupled receptor 155 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR155 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:73,171,850...73,216,842
Ensembl chr 2:73,171,850...73,216,916
|
|
G |
Gpr160 |
G protein-coupled receptor 160 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR160 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:30,909,908...30,951,344
Ensembl chr 3:30,910,099...30,951,341
|
|
G |
Gpr173 |
G-protein coupled receptor 173 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPR173 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:151,126,594...151,151,763
Ensembl chr X:151,126,594...151,151,700
|
|
G |
Gpr20 |
G protein-coupled receptor 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:73,560,346...73,579,354
Ensembl chr15:73,566,453...73,579,354
|
|
G |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR37L1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:135,087,988...135,095,419
Ensembl chr 1:135,087,972...135,095,419
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR87 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:59,086,325...59,102,583
Ensembl chr 3:59,086,344...59,102,525
|
|
G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of GPRC5A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:135,042,660...135,061,707
Ensembl chr 6:135,042,649...135,061,707
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
|
|
G |
Gramd1c |
GRAM domain containing 1C |
increases expression |
ISO |
propionaldehyde results in increased expression of GRAMD1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:43,800,713...43,883,757
Ensembl chr16:43,800,713...43,883,708
|
|
G |
Gramd2b |
GRAM domain containing 2B |
increases expression |
ISO |
propionaldehyde results in increased expression of GRAMD2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:56,533,412...56,636,864
Ensembl chr18:56,533,409...56,636,864
|
|
G |
Greb1l |
growth regulation by estrogen in breast cancer-like |
increases expression |
ISO |
propionaldehyde results in increased expression of GREB1L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:10,324,933...10,562,945
Ensembl chr18:10,325,177...10,562,940
|
|
G |
Grhl1 |
grainyhead like transcription factor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRHL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:24,622,234...24,667,390
Ensembl chr12:24,622,282...24,667,390
|
|
G |
Grhl3 |
grainyhead like transcription factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRHL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:135,269,199...135,300,943
Ensembl chr 4:135,269,199...135,300,941
|
|
G |
Grin2c |
glutamate receptor, ionotropic, NMDA2C (epsilon 3) |
increases expression |
ISO |
propionaldehyde results in increased expression of GRIN2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069
|
|
G |
Grin3b |
glutamate receptor, ionotropic, NMDA3B |
increases expression |
ISO |
propionaldehyde results in increased expression of GRIN3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,806,227...79,813,024
Ensembl chr10:79,806,549...79,813,024
|
|
G |
Grm4 |
glutamate receptor, metabotropic 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRM4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:27,641,361...27,732,800
Ensembl chr17:27,641,361...27,740,377
|
|
G |
Grp |
gastrin releasing peptide |
increases expression |
ISO |
propionaldehyde results in increased expression of GRP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667
|
|
G |
Gsta1 |
glutathione S-transferase, alpha 1 (Ya) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GSTA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
|
|
G |
Gsto2 |
glutathione S-transferase omega 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:47,853,879...47,874,747
Ensembl chr19:47,853,973...47,874,763
|
|
G |
Gtf2ird2 |
GTF2I repeat domain containing 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GTF2IRD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:134,211,629...134,246,988
Ensembl chr 5:134,212,858...134,253,209
|
|
G |
Gtse1 |
G two S phase expressed protein 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GTSE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:85,743,928...85,760,774
Ensembl chr15:85,743,946...85,760,774
|
|
G |
Guca2a |
guanylate cyclase activator 2a (guanylin) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GUCA2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,494,929...119,496,662
Ensembl chr 4:119,494,901...119,496,668
|
|
G |
Gucy1b1 |
guanylate cyclase 1, soluble, beta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GUCY1B1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996
|
|
G |
H19 |
H19, imprinted maternally expressed transcript |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,133,957
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,805,760...23,806,541
Ensembl chr13:23,804,612...23,806,541
|
|
G |
H1f8 |
H1.8 linker histone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:115,921,892...115,927,203
Ensembl chr 6:115,921,899...115,927,197
|
|
G |
H1f9 |
H1.9 linker histone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-9P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:94,858,419...94,859,282
Ensembl chr11:94,858,419...94,859,282
|
|
G |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HLA-DQA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
|
|
G |
H2-M2 |
histocompatibility 2, M region locus 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of HLA-B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
|
|
G |
H2-Oa |
histocompatibility 2, O region alpha locus |
increases expression |
ISO |
propionaldehyde results in increased expression of HLA-DOA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:34,311,353...34,314,286
Ensembl chr17:34,311,314...34,314,208
|
|
G |
H2ac1 |
H2A clustered histone 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:24,118,420...24,118,896
Ensembl chr13:24,118,445...24,118,834
|
|
G |
H2ac20 |
H2A clustered histone 20 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:96,127,728...96,128,209
Ensembl chr 3:96,127,677...96,128,196
|
|
G |
H2ac21 |
H2A clustered histone 21 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:96,127,201...96,127,634
Ensembl chr 3:96,127,181...96,127,624
|
|
G |
H2ac25 |
H2A clustered histone 25 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC25 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:58,845,511...58,846,018
Ensembl chr11:58,845,511...58,847,656
|
|
G |
H2ac4 |
H2A clustered histone 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,935,061...23,935,577
Ensembl chr13:23,935,109...23,935,581
|
|
G |
H2bc6 |
H2B clustered histone 6 |
decreases expression increases methylation |
ISO |
propionaldehyde results in decreased expression of H2BC6 mRNA propionaldehyde results in increased methylation of H2BC6 gene |
CTD |
PMID:26079696 PMID:30002397 |
|
NCBI chr13:23,767,653...23,805,091
Ensembl chr13:23,767,653...23,805,107
|
|
G |
H3c11 |
H3 clustered histone 11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H3C7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:21,967,085...21,967,567
Ensembl chr13:21,967,130...21,967,540
|
|
G |
H3c7 |
H3 clustered histone 7 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H3C15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,728,222...23,729,124
Ensembl chr13:23,728,222...23,729,482
|
|
G |
H3c8 |
H3 clustered histone 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H3C12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,719,588...23,720,079
Ensembl chr13:23,719,592...23,720,121
|
|
G |
H4c1 |
H4 clustered histone 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,944,778...23,945,232
Ensembl chr13:23,944,675...23,945,213
|
|
G |
H4c12 |
H4 clustered histone 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:21,934,315...21,934,723
Ensembl chr13:21,934,364...21,934,675
|
|
G |
H4c18 |
H4 clustered histone 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:22,015,962...22,016,367
Ensembl chr13:22,015,937...22,016,366
|
|
G |
H4c4 |
H4 clustered histone 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,765,551...23,765,952
Ensembl chr13:23,765,581...23,766,718
|
|
G |
H4c8 |
H4 clustered histone 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C9 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:23,715,214...23,715,648
Ensembl chr13:23,715,220...23,715,689
|
|
G |
Habp2 |
hyaluronic acid binding protein 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HABP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:56,275,541...56,309,252
Ensembl chr19:56,275,569...56,309,254
|
|
G |
Hao1 |
hydroxyacid oxidase 1, liver |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HAO1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:134,339,281...134,396,272
Ensembl chr 2:134,339,281...134,396,288
|
|
G |
| |